Beta Bionics Inc. Common Stock
BBNXUnited States
5 filed reports · 270 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 996 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 631 | Dec 2025 |
Financial data
270 concepts · 1,627 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial268 concepts · 1,614 facts · Jun 2024 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value11 · Jun 2024 to Jun 2026
- Allocated share based compensation expense11 · Jun 2024 to Jun 2026
- Allowance for doubtful accounts receivable current11 · Jun 2024 to Jun 2026
- Cash and cash equivalents at carrying value11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · Jun 2024 to Jun 2026
- Comprehensive income net of tax11 · Jun 2024 to Jun 2026
- Cost of goods and services sold (US GAAP)11 · Jun 2024 to Jun 2026
- Fair value adjustment of warrants11 · Jun 2024 to Jun 2026
- General and administrative expense (US GAAP)11 · Jun 2024 to Jun 2026
- Gross profit (US GAAP)11 · Jun 2024 to Jun 2026
- Investment income interest11 · Jun 2024 to Jun 2026
- Lease cost11 · Jun 2024 to Jun 2026
- Net income loss11 · Jun 2024 to Jun 2026
- Nonoperating income expense11 · Jun 2024 to Jun 2026
- Operating expenses (US GAAP)11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
- Operating lease cost11 · Jun 2024 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax11 · Jun 2024 to Jun 2026
- Product warranty accrual11 · Jun 2024 to Jun 2026
- Product warranty accrual payments11 · Jun 2024 to Jun 2026
- Research and development expense11 · Jun 2024 to Jun 2026
- Restricted cash11 · Jun 2024 to Jun 2026
- Revenue11 · Jun 2024 to Jun 2026
- Selling and marketing expense (US GAAP)11 · Jun 2024 to Jun 2026
Geography2 concepts · 13 facts · Sep 2024 to Jun 2026
- Revenue10 · Sep 2024 to Jun 2026
- Number of lease agreements3 · Sep 2025 to Dec 2025
Segments
13 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical2 members · 13 facts
- Non Us10 · Sep 2024 to Jun 2026
- CA3 · Sep 2025 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Oct 2025 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 29, 2026
- FY2026 Q1Apr 21, 2026
- FY2025 Q4Feb 18, 2026
- FY2025 Q3Oct 28, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.